These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15105658)

  • 1. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms.
    Petit A; Castillo M; Santos M; Mellado B; Alcover JB; Mallofré C
    Am J Surg Pathol; 2004 May; 28(5):676-8. PubMed ID: 15105658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma.
    Ahmed EA; Youssif ME
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
    Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
    Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
    An J; Park CK; Kim M; Joo JW; Cho NH
    Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
    Wang HY; Mills SE
    Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
    Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
    Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
    Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
    Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the KIT/stem cell factor axis in renal tumours.
    Horstmann M; Hennenlotter J; Geiger LM; Vogel U; Schmid H; Kuehs U; Stenzl A; Bedke J
    Anticancer Res; 2012 Oct; 32(10):4339-45. PubMed ID: 23060556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
    Geramizadeh B; Ravanshad M; Rahsaz M
    Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M; Delahunt B; Störkel S; Grebem SK
    Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underexpression of hepatocyte nuclear factor-1β in chromophobe renal cell carcinoma.
    Wang CC; Mao TL; Yang WC; Jeng YM
    Histopathology; 2013 Mar; 62(4):589-94. PubMed ID: 23237209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.
    Jain S; Roy S; Amin M; Acquafondata M; Yin M; Laframboise W; Bastacky S; Pantanowitz L; Dhir R; Parwani A
    Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters.
    Tsai WC; Sheu LF; Nieh S; Yu CP; Sun GH; Lin YF; Chen A; Jin JS
    World J Urol; 2007 Mar; 25(1):73-80. PubMed ID: 17021824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typing of renal tumors by morphological and immunocytochemical evaluation of fine needle aspirates.
    Strojan Fležar M; Gutnik H; Jeruc J; Kirbiš IS
    Virchows Arch; 2011 Dec; 459(6):607-14. PubMed ID: 22052200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC; Chen PC; Chiang H
    Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.
    Mai KT; Landry DC; Robertson SJ; Commons AS; Burns BF; Thijssen A; Collins J
    Pathol Res Pract; 2001; 197(10):671-5. PubMed ID: 11700888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
    Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
    Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.